[Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management (Spanish version)]

Rev Gastroenterol Mex. 2015 Jan-Mar;80(1):32-73. doi: 10.1016/j.rgmx.2014.10.007. Epub 2015 Mar 10.

[Article in Spanish]

Authors

A Dignass¹, J O Lindsay², A Sturm³, A Windsor³, J-F Colombel³, M Allez³, G d'Haens³, A d'Hoore³, G Mantzanaris³, G Novacek³, T Öresland³, W Reinisch³, M Sans³, E Stange³, S Vermeire³, S Travis³, G van Assche⁴

Affiliations

¹ Contribuyeron por igual a este trabajo; Coordinadores del Consenso. Electronic address: axel.dignass@fdk.info.
² Contribuyeron por igual a este trabajo.
³ Contribuyeron por igual a este trabajo; Coordinadores del Consenso.
⁴ Coordinadores del Consenso. Electronic address: gvanassche@mtsinai.on.ca.

PMID: 25769217
DOI: 10.1016/j.rgmx.2014.10.007

No abstract available

Keywords: Anastomosis ileoanal con reservorio; Cirugía; Colitis ulcerosa; Inmunosupresor; Tratamiento.

Publication types

Consensus Development Conference
Practice Guideline

MeSH terms

Colitis, Ulcerative / complications
Colitis, Ulcerative / diagnosis*
Colitis, Ulcerative / therapy*
Combined Modality Therapy
Disease Progression
Europe
Gastrointestinal Agents / therapeutic use
Humans
Ileostomy
Immunosuppressive Agents / therapeutic use
Induction Chemotherapy
Maintenance Chemotherapy
Proctocolectomy, Restorative
Severity of Illness Index

Substances

Gastrointestinal Agents
Immunosuppressive Agents